• O-GlcNAcylation Controls HUWE1-TfR1 Axis in Preeclampsia Fer

  2026-06-11

  This study reveals how O-GlcNAc modification of the E3 ligase HUWE1 regulates transferrin receptor 1 (TfR1) degradation and ferroptosis in placental trophoblasts, a mechanism central to preeclampsia pathology. The findings highlight the therapeutic potential of targeting the O-GlcNAc–HUWE1–TfR1 axis to mitigate trophoblast stress and improve pregnancy outcomes.

• Vernakalant Hydrochloride: Rapid AF Conversion and Ion Chann

  2026-06-10

  Vernakalant Hydrochloride (RSD1235) delivers rapid, atrial-selective conversion of atrial fibrillation by uniquely targeting multiple ion channels with minimal ventricular effects. This guide details practical experimental workflows, troubleshooting insights, and key innovations from landmark studies, empowering researchers and clinicians to harness its full translational potential.

• ISRIB (trans-isomer): Evidence-Based PERK Inhibitor for ER S

  2026-06-10

  ISRIB (trans-isomer) is a potent PERK inhibitor that reverses eIF2α phosphorylation to restore translation during ER stress. Its robust efficacy in neuroinflammation and memory models is supported by recent evidence. APExBIO supplies this compound for advanced ER stress and cognitive research.

• HDAC Inhibition and Drug Synergy in Pancreatic Cancer Models

  2026-06-09

  This study introduces a rapid in vivo screening platform using Rgs16::GFP expression to identify effective chemotherapeutic combinations for pancreatic ductal adenocarcinoma (PDA). The research highlights how the HDAC inhibitor Trichostatin A (TSA) enhances cytotoxicity of standard agents, underscoring the translational potential of epigenetic modulation in PDA therapy.

• 5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: Mechanistic

  2026-06-09

  This study systematically investigates how 5-HT3 receptor antagonists, including tropisetron, inhibit renal organic cation transporters OCT2 and MATE1 in vitro. The findings reveal drug-specific differences in transporter inhibition, highlighting potential implications for drug-drug interactions and the pharmacokinetics of cationic therapeutics.

• Bromodomain Inhibitor, (+)-JQ1: Reliable BET Assay Solutions

  2026-06-08

  This article guides biomedical researchers and laboratory professionals through practical, scenario-driven challenges in BET bromodomain inhibition workflows. Drawing from recent literature and real-world protocol needs, we demonstrate how Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) delivers reproducible, data-validated performance for apoptosis assays, inflammation modulation, and BRDT-targeted studies.

• Electrostatic Insights: Cy5 Maleimide (Non-sulfonated) for P

  2026-06-08

  Explore how Cy5 maleimide (non-sulfonated) enables advanced, charge-dependent protein labeling and partitioning. This article reveals new electrostatic considerations for probe design that go beyond standard thiol-reactive dye applications.

• Scenario-Driven Solutions with Pazopanib (GW-786034) in Canc

  2026-06-07

  This article addresses real lab challenges in cell viability and tumor biology assays, highlighting how Pazopanib (GW-786034) (SKU A3022) from APExBIO delivers reliable, reproducible results. Readers will find scenario-based guidance, quantitative context, and practical protocol parameters to optimize workflows using this multi-targeted RTK inhibitor.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-06-06

  This study provides a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong Province during the COVID-19 pandemic. The findings illuminate the prevalence, transmission mechanisms, and multidrug resistance profiles of CREC, with significant implications for antibiotic resistance research and clinical microbiology workflows.

• Tropisetron Hydrochloride: Unraveling Renal Transport and 5-

  2026-06-05

  Explore the unique role of Tropisetron Hydrochloride as a 5-HT3 receptor antagonist in dissecting renal drug transport and serotonin pathway modulation. This article delivers advanced insights for neuroscience receptor modulation and transporter assay design.

• Isoproterenol Sulfate Dihydrate: Benchmarks for Beta-Adrener

  2026-06-05

  Isoproterenol sulfate dihydrate (SKU C6402) is a high-purity, non-selective beta-adrenergic agonist widely used to model cardiovascular and GPCR signaling. Its reliable solubility and well-characterized receptor activity make it a standard in studies of pacemaker physiology and neuro-cardiac interactions. Stringent verification by HPLC and NMR ensures consistent results for research applications.

• Sabutoclax: Pan-Bcl-2 Inhibitor Workflows for Cancer Models

  2026-06-04

  Sabutoclax stands out as a potent, membrane-permeable pan-Bcl-2 inhibitor, enabling precise apoptosis induction in resistant cancer models. This guide translates recent systems-level findings into actionable protocols, troubleshooting strategies, and comparative advantages for reproducible, high-fidelity cancer research.

• Everolimus (RAD001): Precision Dosing and Assay Interpretati

  2026-06-04

  Explore Everolimus (RAD001) in the context of precision dosing and quantitative assay interpretation for cancer research. This article uniquely addresses practical workflow integration and evidence-based assay strategies, advancing beyond mechanistic overviews.

• Maraviroc (UK-427857): Applied Workflows in CCR5-Targeted Re

  2026-06-03

  Maraviroc (UK-427857) is redefining experimental strategies in HIV-1 entry inhibition and inflammatory disease models. This article delivers detailed protocols, troubleshooting insights, and practical guidance for maximizing the utility of Maraviroc in both virology and immunopathology research.

• MDL 28170: Transforming Calpain Inhibition for Translational

  2026-06-03

  Explore how MDL 28170, a potent calpain inhibitor, is reshaping translational research in neuroprotection, cardiac injury, and infectious disease models. This thought-leadership article delves into mechanistic insights, protocol strategies, and evidence-based guidance for leveraging selective calpain and cathepsin B inhibition in advanced experimental designs.

3765 records 15/251 page Previous Next First page 上5页 1112131415 下5页 Last page